Maximilian Stahl
Academic History
Maximilian Stahl, MD, is an Assistant Professor of Medicine and Director of the Leukemia and Myeloid Malignancy Program at Yale Cancer Center, New Haven, CT. Stahl joined Yale from Dana-Farber Cancer Institute and Harvard Medical School, where he was an Assistant Professor of Medicine. He received his medical degree from Hannover Medical School, Hannover, Germany, before completing his residency in Internal Medicine and serving as chief medical resident at the Yale School of Medicine, New Haven, CT. He went on to complete a fellowship in Hematology and Oncology at Memorial Sloan Kettering Cancer Center, New York, NY.
Speaking on clinical trials and therapeutic strategies in AML and MDS
Dr Stahl specializes in the clinical development of early-phase trials for acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS), with a focus on treatment outcomes, risk stratification, and real-world data analysis. His research aims to refine diagnostic and therapeutic approaches in myeloid malignancies, including cost-effectiveness studies and the impact of molecular markers on prognosis and therapy.
